Applying this optimised framework to AD GWAS data, we recovered high-priority proof-of-concept targets within the top 1% of ranked genes (a total of ∼14,500 genes ranked by their priority ratings), including APP, ESR1, KIT, and PDGFRB (Fig. 2, right panel). This evidence concerns the gene APP and Alzheimer disease.